The activity of Levisticum officinale W.D.J. Koch essential oil against multidrug-resistant Mycobacterium tuberclosis
AbstractBackground and Objectives: Essential oils are used for controlling and preventing human diseases and the application of those can often be quite safe and effective with no side effect. The essential oils have been found to have antiparasitic, antifungal, antiviral, antioxidant and especially antibacterial activity including antibacterial activity against tuberculosis. In this study the chemical composition and anti-TB activity of essential oil extracted from Levisticum officinale has been evaluated.Materials and Methods: The essential oil of L. officinale was obtained by the hydro distillation method and the oil was analyzed by GC-FID and GC-MS techniques. The antibacterial activity of essential oil was evaluated through Minimum Inhibitory Concentration (MIC) assay using micro broth dilution method against multidrug-resistant Maycobacterium tuberculosis. The molecular modeling of major compounds was evaluated through molecular docking using Auto Dock Vina against-2-trans-enoyl-ACP reductase (InhA) as key enzyme in M. tuberclosis cell wall biosynthesis. Results: The hydrodistillation on aerial parts of L. officinale yielded 2.5% v/w of essential oil. The major compounds of essential oil were identified as α-terpinenyl acetate (52.85%), β- phellandrene (10.26%) and neocnidilide (10.12%). The essential oil showed relatively good anti-MDR M. tuberculosis with MIC = 252 μg/ml. The results of Molecular Docking showed that affinity of major compounds was comparable to isoniazid.Conclusion: The essential oil of aerial parts extracted from L. officinale was relatively active against MDR M. tuberculosis, and molecular docking showed the major compounds had high affinity to inhibit 2-trans-enoyl-acyl carrier protein reductase (InhA) as an important enzyme in M. tuberculosis cell wall biosynthesis.
- Taiwo MO, Adebayo OS. Plant Essential Oil: An Alternative to Emerging Multidrug Resistant Pathogens. J Microbiol Exp. 2017; 5(5): 1-6.
- Edris AE. Pharmaceutical and Therapeutic Potentials of Essential Oils and Their Individual Volatile Constituents: A Review. Phytother Res. 2007; 21(4): 308-323.
- Sergio AO, Fabiola CV, Guadalupe NM. Evaluation of antimycobacterium activity of the essential oils of cumin (Cuminum cyminum), clove (Eugenia caryophyllata), cinnamon (Cinnamomum verum), laurel (Laurus nobilis) and anis (Pimpinella anisum) against Mycobacterium tuberculosis. Adv Biol Chem. 2013; 3: 480-484.
- Bueno J, Escobar P, Martínez JR, Leal SM, Stashenko EE. Composition of Three Essential Oils, and their Mammalian Cell Toxicity and Antimycobacterial Activity against Drug Resistant-Tuberculosis and Nontuberculous Mycobacteria Strains. Nat Prod Commun. 2011;6(11): 1743-1748
- Mozaffarian V. Identification of medicinal and aromatic plants of Iran. Tehran: Farhang Moaser Press, 2013.
- Duke JA. The Green Pharmacy. Rodale Press, 1997.
- Mirjalili MH, Salehi P, Sonboli A, Hadian J, Ebrahimi SN, Yousefzadi M. The composition and antibacterial activity of the essential oil of Levisticum officinale Koch. Flowers and fruits at different developmental stages. J Serb Chem Soc. 2010;75 (12): 1661-1669.
- Schinkovitz A, Stavri M, Gibbons S Bucar F. Antimycobacterial Polyacetylenes from Levisticum ofﬁcinale. Phytother Res. 2008;22: 681-684.
- Guzman JD, Evangelopoulos D, Gupta A, Prieto JM, Gibbons S, Bhakta S. Antimycobacterials from lovage root (Ligusticum officinale Koch). Phytother Res. 2013;27: 993-998.
- Adams RP. Identification of Essential Oil Components by Gas Chromatography/mass Spectorscopy. Allured Publishing Corporation, 2007.
- McLafferty FW. Wiley Registry of Mass Spectral Data. Upgrade. Wiley, 2009.
- Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 2010;31(2):451-461.
- Jamil AS, Mohammad TA, Sanjib S, Shihab H, Alexander G, Véronique S. Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora. In Silico Pharmacol. 2015;3(10):1-7.
- Zakerbostanabad S, Titov LP, Bahrmand AR. Frequency and molecular characterization of isoniazid resistance in katG region of MDR isolates from tuberculosis patients in southern endemic border of Iran. Infect Genet Evol. 2008;8:15-19.
- Nasiri MJ, Rezaei F, Zamani S, Darban-Sarokhalil D, Fooladi A.A, Shojaei H, Feizabadi MM. Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran. Asian Pac J Trop Med. 7, 2014;193-196.
- Coban AY, Birinci A, Ekinci B, Durupinar B. Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth. Mem. Inst. Oswaldo Cruz. 2004;99: 111-113.
- Askun T, Tekwu EM, Satil F, Modanlioglu S, Aydeniz H. Preliminary antimycobacterial study on selected Turkish plants (Lamiaceae) against Mycobacterium tuberculosis and search for some phenolic constituents. BMC Complement Altern Med. 2013;13:365-376.
- Mirjalili MH, Javanmardi J. Handbook of Herbs and Spices. Abington: Peter KV, Ed. Woodhead Publishing Ltd, 2006.
- Riz V, Hadjiakhoondi A. The essential oil composition of levisticum officinalis from Iran. Asian J. Chem. 2007;2(2):161-163.
- Raal A, Arak E, Orav A, Kailas T, Müürisepp M. Composition of the Essential Oil of Levisticum officinale Koch from Some European Countries. J. Essent. Oil Res. 2008;318-322.
- Kardan YJ, Haeili M, Gizaw Feyisa S, Kazemian H, Hashemi A, Shahraki F, Zahednamazi AA, Fooladi I Feizabadi MM. Evaluation of efflux pump gene expression among drug susceptible and drug resistant strains of Mycobacterium tuberculosis from Iran. Infect Genet Evol. 2015;36:23-26.
- Ma C, Case R.J, Wang Y, Zhang HJ, Tan GT, Hung NV, Cuong NM, Franzblau S.G, Soejarto DD, Fong HHS, Pauli G.F. Anti-Tuberculosis Constituents from the Stem Bark of Micromelum hirsutum. Planta Med. 2005;71(3):261-267.
- Macabeo APG, Vidar WS, Chen X, Decker M, Heilmann J, Wan B, Franzblau S.G, Galvez EV, Aguinaldo MAM, Cordell GA. Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa. Eur J Med Chem. 2011;46: 3118-3123.
- Marrakchi H, Laneelle G, Quemard A. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology. 2000; 146:289-296.